Drug name - Diprivan
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US8476010 | FRESENIUS KABI USA | Propofol formulations with non-reactive container closures |
Dec, 2024
(2 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
|
US8476010
(Pediatric) | FRESENIUS KABI USA | Propofol formulations with non-reactive container closures |
Jun, 2025
(2 years from now) | |
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 10MG/ML | INJECTABLE;INJECTION | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.